[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$f1kafsnx33bcjd":5},{"data":4},[],{"data":6,"error":10},{"id":7,"documentId":8,"slug":9,"name":9,"proprietary_name":10,"non_proprietary_name":10,"is_proprietary":10,"active_ingredient":11,"administration_route":12,"available_strength":10,"dosage_form":13,"dose_schedule":14,"drug_unit":10,"is_available_generically":10,"mechanism_of_action":10,"overdosage":15,"warning":16,"species":17,"citations":18,"dose_schedules":31,"available_strengths":50,"label_statements":58,"drug_classes":80,"specialties":86,"medical_conditions":87,"animal_species":93},1885,"i2cfrfuu84n9n84aq1rripjr","clenbuterol",null,"Each ml contains:\r \r  Active substance:\r  Clenbuterol hydrochloride 30 micrograms\r  Preservative:\r  Benzyl alcohol 10 mg\u002Fml\r \r  For a full list of excipients, see section 6.1","intravenous","Solution for injection.","Administer by slow intravenous injection at a dose of 2.7 ml per 100 kg\r  bodyweight twice daily for as long as necessary.","necessary\r\n\r\n See Section 4.6 for likely clinical effects. In case of accidental overdose,\r\n a -blocker such as propanolol may be used.","Do not use in horses with known cardiac disease.",[],[19],{"covers":20,"source":27,"licence":28,"source_url":29,"retrieved_at":30},[21,22,23,24,25,26],"active_ingredient","administration_route","dosage_form","dose_schedule","overdosage","warning","UK VMD Summary of Product Characteristics","Crown copyright, Open Government Licence v3.0","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002FProductInformationDatabase\u002Ffiles\u002FSPC_Documents\u002FSPC_115434.PDF","2026-09-20",[32,39,44,47],{"id":33,"dose_text":34,"species":35,"administration_route":36,"limitation":37,"source_label":38},13867,"Administer orally twice a day. Initial dose is 0.5 milliliter per 100 pounds body weight (0.8 micrograms per kilogram) for 3 days (6 treatments). If no improvement, administer 1 milliliter per 100 pounds (1.6 micrograms per kilogram) for 3 days (6 treatments). If no improvement, administer 1.5 milliliters per 100 pounds (2.4 micrograms per kilogram) for 3 days (6 treatments). If no improvement, administer 2.0 milliliters per 100 pounds (3.2 micrograms per kilogram) for 3 days (6 treatments). If no improvement, horse is nonresponder to clenbuterol and treatment should be discontinued.","Horses","Oral","Treat at effective dose for 30 days. At the end of the 30-day treatment period, drug should be withdrawn. If signs return, the 30-day treatment period may be repeated. If repeating treatment, the step-wise dosage schedule should be repeated. The effect of this drug on breeding stallions and brood mares has not been determined. Treatment starting with dosages higher than the initial dose is not recommended. Federal law prohibits the extra label use of this drug in food animals. Federal law restricts this drug to use by or on the order of a licensed veterinarian.","Ventipulmin® Syrup",{"id":40,"dose_text":41,"species":10,"administration_route":42,"limitation":10,"source_label":43},13868,"Initial dosage: administer 0.5 mL\u002F100 lbs (0.8 mcg\u002Fkg) for 3 days (6 treatments); If no improvement, administer 1.0 mL\u002F100 lbs (1.6 mcg\u002Fkg) for 3 days (6 treatments); If no improvement, administer 1.5 mL\u002F100 lbs (2.4 mcg\u002Fkg) for 3 days (6 treatments); If no improvement, administer 2.0 mL\u002F100 lbs (3.2 mcg\u002Fkg) for 3 days (6 treatments); If no improvement, horse is non-responsive to clenbuterol and treatment should be discontinued. Recommended duration of treatment at effective dose is 30 days. At the end of this 30-day treatment period, drug should be withdrawn to determine recurrence of signs. If signs return, the 30-day treatment regimen may be repeated. If repeating treatment, the step-wise dosage schedule should be repeated.","ORAL","Ventipulmin® Syrup (clenbuterol HCl)",{"id":45,"dose_text":46,"species":10,"administration_route":42,"limitation":10,"source_label":43},13869,"Lbs. Body\nWeight\nmL\u002Ftreatment\nat 0.5 mL\u002F100#\n(0.8 mcg\u002Fkg)\nmL\u002Ftreatment\nat 1.0 mL\u002F100#\n(1.6 mcg\u002Fkg)\nmL\u002Ftreatment\nat 1.5 mL\u002F100#\n(2.4 mcg\u002Fkg)\nmL\u002Ftreatment\nat 2.0 mL\u002F100#\n(3.2 mcg\u002Fkg)\n500\n600\n700\n800\n900\n1000\n1100\n1200\n1300\n1400\n1500\n1600\n1700\n1800\n2.5\n3.0\n3.5\n4.0\n4.5\n5.0\n5.5\n6.0\n6.5\n7.0\n7.5\n8.0\n8.5\n9.0\n5.0\n6.0\n7.0\n8.0\n9.0\n10.0\n11.0\n12.0\n13.0\n14.0\n15.0\n16.0\n17.0\n18.0\n7.5\n9.0\n10.5\n12.0\n13.5\n15.0\n16.5\n18.0\n19.5\n21.0\n22.5\n24.0\n25.5\n27.0\n10.0\n12.0\n14.0\n16.0\n18.0\n20.0\n22.0\n24.0\n26.0\n28.0\n30.0\n32.0\n34.0\n36.0\nAdminister two treatments per day.",{"id":48,"dose_text":49,"species":10,"administration_route":42,"limitation":10,"source_label":43},13870,"Administer orally twice a day (b.i.d.). Initial dose is 0.5 mL\u002F100 lbs body weight (0.8 mcg\u002Fkg) twice daily.",[51,55],{"id":52,"strength_text":53,"dosage_form":54,"proprietary_name":38,"species":35,"source_label":38},12043,"Each milliliter contains 72.5 micrograms of clenbuterol hydrochloride.","Syrup",{"id":56,"strength_text":57,"dosage_form":10,"proprietary_name":10,"species":10,"source_label":43},12044,"0.0725 mg \u002F 1 mL",[59,63,66,70,73,76],{"id":60,"kind":61,"statement":62,"species":35,"limitation":37,"source_label":38},20421,"indication","Indicated for the management of horses affected with airway obstruction, such as occurs in chronic obstructive pulmonary disease (COPD).",{"id":64,"kind":61,"statement":65,"species":10,"limitation":10,"source_label":43},20422,"VENTIPULMIN Syrup (clenbuterol hydrochloride) is indicated for the management of horses affected with airway obstruction, such as occurs in chronic obstructive pulmonary disease (COPD).",{"id":67,"kind":68,"statement":69,"species":10,"limitation":10,"source_label":43},20423,"contraindication","VENTIPULMIN Syrup antagonizes the effects of prostaglandin F2 α and oxytocin. VENTIPULMIN Syrup should not be used in pregnant mares near term. Because tachycardia may occur, VENTIPULMIN Syrup should not be used in horses suspected of having cardiovascular impairment.",{"id":71,"kind":26,"statement":72,"species":10,"limitation":10,"source_label":43},20424,"Not for use in humans. Do not use in horses intended for human consumption. Keep out of reach of children. In case of accidental ingestion, contact a physician immediately. Ingestion of VENTIPULMIN Syrup may cause undesirable reactions. Clenbuterol, like other beta adrenergic agonists, can produce significant cardiovascular effects in some people as evidenced by elevated pulse rate, blood pressure changes and\u002For ECG changes.",{"id":74,"kind":26,"statement":75,"species":10,"limitation":10,"source_label":43},20425,"The effect on reproduction in breeding stallions and brood mares has not been determined. Treatment starting with dosages higher than the initial dose is not recommended.",{"id":77,"kind":78,"statement":79,"species":10,"limitation":10,"source_label":43},20426,"adverse_reaction","Mild sweating, muscle tremor, restlessness, urticaria and tachycardia may be observed in some horses during the first few days of treatment. May cause elevated creatine kinase (CK) serum levels. Ataxia was observed in 3 out of 239 horses (1.3%) in clinical studies. To report suspected adverse events, for technical assistance, or to obtain a copy of the Safety Data Sheet (SDS), contact Boehringer Ingelheim Animal Health USA Inc. at 1-888-637-4251. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at www.fda.gov\u002Freportanimalae.",[81],{"id":82,"documentId":83,"slug":84,"name":85},1011,"sdke7a6pwyh44bh56av2pj6v","selective-beta-2-adrenoreceptor-agonists","Selective beta-2-adrenoreceptor agonists",[],[88],{"id":89,"documentId":90,"slug":91,"title":92},108,"xpbsvrxyrdwbyn40hesgvzol","chronic-obstructive-pulmonary-disease","Chronic obstructive pulmonary disease",[]]